Mannkind (MNKD) EBT Margin (2010 - 2026)

Mannkind's (MNKD) quarterly EBT Margin came in at 18.15% in Q1 2026, down 3553.0% year-on-year from 0.53% in Q1 2025, and up 2.92% on a QoQ basis from 18.7% in Q4 2025.

Mannkind (MNKD) EBT Margin (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 14 years of EBT Margin data on file, last reported at 18.15% in Q1 2026.

  • On a quarterly basis, EBT Margin fell 3553.0% year-over-year to 18.15% in Q1 2026; TTM through Mar 2026 was 7.92%, a 1909.0% decrease from a year earlier, with the FY2025 full-year figure at 0.4%, down 1029.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 18.15%, up from 18.7% in the prior quarter.
  • Over the last five years, EBT Margin for MNKD reached as high as 18.36% in Q3 2024 and fell as low as 216.79% in Q1 2022.
  • Historically, EBT Margin has averaged 26.82% across 5 years, with a median of 2.34% in 2024.
  • Across the five-year window, EBT Margin plunged 14272 bps in 2022 and jumped 19268 bps in 2023, its largest moves.
  • Year by year, EBT Margin stood at 49.77% in 2022, then soared by 110 bps to 5.07% in 2023, then soared by 117 bps to 11.0% in 2024, then plunged by 270 bps to 18.7% in 2025, then grew by 3 bps to 18.15% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 18.15% in Q1 2026, 18.7% in Q4 2025, and 9.47% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn -18.15%

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.15%
Dec 31, 2025 -18.70%
Sep 30, 2025 9.47%
Jun 30, 2025 1.23%
Mar 31, 2025 17.38%
Dec 31, 2024 11.00%
Sep 30, 2024 18.36%
Jun 30, 2024 -2.34%
Mar 31, 2024 16.44%
Dec 31, 2023 5.07%
Sep 30, 2023 3.36%
Jun 30, 2023 -10.83%
Mar 31, 2023 -24.11%
Dec 31, 2022 -49.77%
Sep 30, 2022 -43.97%
Jun 30, 2022 -153.61%
Mar 31, 2022 -216.79%
Dec 31, 2021 -224.22%
Sep 30, 2021 -19.93%
Jun 30, 2021 -152.59%